CSPC PHARMACEUTICAL GROUP ADR's ticker is CSPCY and the CUSIP is 12591J207. A total of 1 filers reported holding CSPC PHARMACEUTICAL GROUP ADR in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,834,900 | -9.5% | 527,877 | +2.4% | 0.00% | 0.0% |
| Q1 2023 | $2,028,491 | +97283.1% | 515,657 | +4.0% | 0.00% | 0.0% |
| Q4 2022 | $2,083 | -99.9% | 495,617 | +3.4% | 0.00% | 0.0% |
| Q3 2022 | $1,901,000 | -12.6% | 479,536 | -12.4% | 0.00% | -50.0% |
| Q2 2022 | $2,174,000 | -0.9% | 547,427 | +15.4% | 0.00% | +100.0% |
| Q1 2022 | $2,193,000 | +16.8% | 474,502 | +9.8% | 0.00% | 0.0% |
| Q4 2021 | $1,878,000 | -12.4% | 432,134 | -3.2% | 0.00% | 0.0% |
| Q3 2021 | $2,143,000 | -39.8% | 446,436 | -27.4% | 0.00% | -50.0% |
| Q2 2021 | $3,561,000 | +14.6% | 615,053 | -4.2% | 0.00% | 0.0% |
| Q1 2021 | $3,106,000 | +3.1% | 642,203 | -12.8% | 0.00% | 0.0% |
| Q4 2020 | $3,012,000 | +114.4% | 736,327 | +305.9% | 0.00% | +100.0% |
| Q3 2020 | $1,405,000 | +56.5% | 181,420 | +49.9% | 0.00% | 0.0% |
| Q2 2020 | $898,000 | +87.9% | 121,033 | +102.7% | 0.00% | 0.0% |
| Q1 2020 | $478,000 | -15.8% | 59,722 | -15.6% | 0.00% | 0.0% |
| Q3 2019 | $568,000 | +65.6% | 70,771 | +33.1% | 0.00% | – |
| Q2 2019 | $343,000 | +3.0% | 53,158 | +18.8% | 0.00% | – |
| Q1 2019 | $333,000 | – | 44,753 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OLD MISSION CAPITAL LLC | 454,388 | $1,787,562 | 0.04% |
| FNY Investment Advisers, LLC | 2,500 | $9 | 0.01% |
| Systematic Alpha Investments, LLC | 29,700 | $116,839 | 0.01% |
| Fisher Asset Management, LLC | 515,657 | $2,028,491 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 33,404 | $131,411 | 0.00% |